Journal of the European Academy of Dermatology and Venereology

Article	Citations
Announcement	363
Editor's Picks January 2024	234
Announcement	232
	121
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	112
Announcement	111
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	110
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	106
Reply to comments by Tadulewicz and Muklewicz on socio‐economic outcomes of atopic dermatitis	102
Louis Adolphus Duhring: An enduring legacy	97
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	85
Advances in biologic therapy of psoriasis	84
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	80
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	73
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	72
Are non‐fungible tokens the barrier to realizing the Dermoverse?	71
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	71
Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial	71
Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study	68
Global burden of major depressive disorder attributable to psoriasis, 2000–2021	67
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	63
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	61
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine	60
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	58
Issue Information	57

	57
Impact of menopause on the skin…information still insufficient	57
	56
Announcement	56
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	56
Announcement	55
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	54
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	53
Juvenile localized scleroderma: A single‐centre experience from India	53
Dalbavancin for the treatment of severe hidradenitis suppurativa	52
A case of eruptive halo nevi following COVID‐19	50
The chicken or the egg of lymphopenia in atopic eczema	50
The future of digital pills and their potential use in dermatological clinical trials	49
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	49
Pharmacovigilance: The responsibility of all	49
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	48
Editor’s Picks June 2025	48
Educational, labour market and relationship outcomes in people with acne	48
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	48
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	47
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	45
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	44
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	44
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	42
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US	42
Chat GPT in dermatology: Progressive or problematic?	41
Peer review, scientific publishing and the law of reciprocity	41
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	41
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	41
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	40
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	39
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment	39
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	39
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	39
Biomarkers in rosacea: A systematic review	38
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis	38
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	37
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	37
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	37
NPWT in skin transplantation: Promising, but is the jury still out?	37
Efficacy of imiquimod in the management of lentigo maligna	37
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	36
Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’	36
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	36
A new era for alopecia areata: New treatments and improved knowledge of the condition	36
Treatment of juvenile localized scleroderma with upadacitinib: A case series	36
Two cases of cerebrovascular accidents following the induction dose of risankizumab	36
Urinary incontinence and female genital lichen sclerosus	35
Editor’s Picks February 2026	35
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	35

Editor’s Picks December 2025	35
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024	35
Patterns of regret for inadequate sun protection: A population‐based study [ HELIOS ]	34
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	34
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	34
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	34
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	33
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	33
Application of integrated skincare in medical aesthetics: A literature review	33
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	33
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	33
Predictors of clinical response to biologics in psoriasis: A systematic review and meta‐analysis	33
Systemic effects of sunlight: 10‐year review of cardiovascular, infection and cancer outcomes	32
Genomic and proteomic insights into hidradenitis suppurativa	32
Paediatric psoriasis and biologics: An evidence gap in plain sight	32
Microinfusion of 5‐fluorouracil using a tattooing machine in keloid treatment	31
The need for African dermatology guidelines—Steps towards equitable care	31
Can we trust AI for acne advice: A double‐blind performance comparison with NICE guidelines	31
Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management	31
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	31
Translating 6‐year trial safety data of upadacitinib in atopic dermatitis into clinical practice	31
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis	31
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	30
Announcement	30
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	30
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	30
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	30
Delphi consensus on melasma management by international experts and pigmentary disorders society	30
Issue Information	29
Commentary to ‘Development of a patient‐reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.	29
Announcement	29
	29
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	29
	29
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	28
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	28
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	28
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	28
	28
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	28
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	28
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	28
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	27
High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid	27
EADO classification of difficult‐to‐treat cutaneous squamous cell carcinoma in transplant recipients	27
Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	27
Morphoea en coup de sabre with Adie's pupil: An exceptional association	27
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	27
Deciphering differential response to NB‐UVB: The hair matters	27
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	27
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	27
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	27
Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.	26
Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies	26
Optical coherence tomography to differentiate squamous cell carcinoma from Bowen's disease and actinic keratosis	26
Modest psoriasis risk from cardiometabolic progression: Genetics, patterns and limitations in a Biobank study	26
Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment	26
Erectile dysfunction in patients with seborrhoeic dermatitis	26
JAK inhibitor treatment for non‐infectious granulomatous skin diseases—A retrospective case study	26
Thromboembolic risk with JAK inhibitors in atopic dermatitis: Context, caution and clinical relevance	26
A special thank you to our reviewers!	26
	25
Announcement	25
	25
Announcement	25
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	25
	25
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	25
Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24‐week real‐world case series	24
Burnout among French dermatologists: A national study	24
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	24
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	24
Scratching the surface: NK‐1 inhibitors for chronic itch—Promise or placebo?	24
Cocaine‐induced plasma cell mucositis with osteocartilaginous destruction and atypical p‐ ANCA	24
Dermatologic adverse events associated with amivantamab: A multicentre study	24
Scabies revisited in the COVID‐19 era	24
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	24
Response to Letter to the Editor—Assessing UWB‐RSOM for non‐invasive melanoma depth: Diagnostic potential and critical limitations	24
Beyond the surface: Integrating sex and gender in dermatologic therapy	24
AI‐assisted basal cell carcinoma diagnosis with LC‐OCT: A multicentric retrospective study	24

Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction	24
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	23
Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics	23
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	23
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	23
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	23
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	23
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	23
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	23
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	23
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	23
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	23
Severity strata and minimally important differences of CompAQ and Skindex‐16 for patients with acne	23
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	23
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	23
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	23
Chronic pruritus in multiple sclerosis and clinical correlates	23
Announcement	22
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	22
Real‐world outcomes of biologics for hidradenitis suppurativa: A systematic review and meta‐analysis	22
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	22
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	22
Linear and whorled hypermelanosis: A multicentre retrospective cohort of 33 patients	22
Global consensus on the management of melanin hyperpigmentation disorders	22
Is risankizumab as needed administration a good option for patients with plaque psoriasis?	22
From COVID‐19 to war – life of a dermatological journal in times of crisis	22
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	22
Beta‐blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review	22
Timing, age and immune profiling refine strategy in lichenoid chronic GVHD – Authors' reply	22
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	22
Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience	21
AI‐assisted diagnosis of basal cell carcinoma via line‐field confocal OCT: Insights and limitations	21
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	21
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	21
Culture‐based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients	21
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	21
Beyond surface: Rethinking prognostic boundaries in early mycosis fungoides	21
Racial representation in dermatology clinical trials, a Canadian perspective	21
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	21
Neuropathy as an early warning sign of desmoplastic neurotropic melanoma of the head	21
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study	21
Immunotherapy versus targeted therapy for BRAF ‐mutant melanoma: A systematic review and meta‐analysis	21
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	21
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	21
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	21
Granular parakeratosis	20
Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up	20
	20
Probing into functional decline among bullous pemphigoid patients	20
Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angio	20
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study	20
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	20
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	20
Announcement	20
Response to comment on ‘Adj‐ PD ‐1 antibody vs. observation for resected nail apparatus melanoma’	20
Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning	20
Premature skin ageing signs due to androgen deprivation therapy	20
Lentigo maligna: A retrospective analysis of 50 cases treated with imiquimod monitored with non‐invasive reflectance confocal microscopy	20
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	19
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	19
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	19
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors	19
Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?	19
Non‐invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM‐OCT imaging device: a case‐series	19
Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain‐of‐function mutation	19
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	19
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	19
Hidradenitis suppurativa: A prospective epidemiologic study in Albania	19
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	19
Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study	19
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients	19
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	19
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	19
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis	19
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	19
Store‐and‐forward mobile application as an accessible method of study participant assessment	18
Concordance of in vivo reflectance confocal microscopy and horizontal‐sectioning histology in skin tumours	18
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study	18
A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections	18
Trichophyton mentagrophytesITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon	18
Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid	18
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	18
Advances in image‐based diagnosis of nail disorders	18
Nonsense mutations in KRT1 caused recessive epidermolytic palmoplantar keratoderma with knuckle pads	18
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature	18
Dual impact of smoking cessation and post‐cessation weight change on psoriasis	18
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial	18
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study	18
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	18
Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’	18
Merkel cell carcinoma after solid organ transplant	18
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry	18
Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe	18
Defining ambiguity in molecular differentiation of psoriasis and eczema	18
Improvement of redness and hyperkeratosis in a case of Nagashima‐type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis	18